Maintaining Autonomy as we Age: A Strategy Training Approach to Ameliorating the Effects of Age-related Executive Dysfunction.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Deirdre Dawson, Baycrest
ClinicalTrials.gov Identifier:
NCT01163279
First received: July 14, 2010
Last updated: March 21, 2012
Last verified: March 2012
  Purpose

Healthy older adults with self-reported cognitive difficulties who receive strategy training will demonstrate greater performance benefits on measures of real-world activities, relative to those receiving a control intervention, immediately post treatment and at follow-up.


Condition Intervention Phase
Aged
Behavioral: Real world strategy approach
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Official Title: Maintaining Autonomy as we Age: Investigating the Application of a Strategy Training Approach for Ameliorating the Effects of Age-related Executive Dysfunction - Part II

Further study details as provided by Baycrest:

Primary Outcome Measures:
  • Changes in performance on Canadian Occupational Performance Measure (COPM) [ Time Frame: One year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Changes in neuropsychological assessments of executive functions [ Time Frame: One year ] [ Designated as safety issue: No ]

Enrollment: 19
Study Start Date: August 2010
Study Completion Date: October 2011
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Real world strategy approach
    The key features of the protocol are: i. Participants are actively engaged in selecting their treatment goals. The research clinician will work with the participants to identify five specific, measurable real-world goals using a standardized semi-structured interview, the Canadian Occupational Performance Measure. Three of these will be training goals, two will not be trained but evaluated post-intervention for evidence of generalization and transfer to non-trained tasks; ii. A global problem solving approach is used (Goal- Plan- Do- Check). Participants are guided by the trainer to apply this strategy to their goals.
    Other Name: Adopted CO-OP
  Eligibility

Ages Eligible for Study:   65 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All participants must score within 1.5 SDs of age and education-corrected normative data for the Montreal Cognitive Assessment and on a battery of neuropsychological tests of attention, memory and executive function (which will insure that participants are unlikely to meet the criteria for MCI).
  • No clinically relevant depression (scores ≤22) on the CES-D
  • Fluent in written and spoken English
  • Self-reported complains about cognitive function

Exclusion Criteria:

  • Recent bereavement (within last 6 months)
  • History of neurological disease
  • Psychiatric illness requiring hospitalization and/or history or current substance abuse
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01163279

Locations
Canada, Ontario
Baycrest
Toronto, Ontario, Canada, M6A 2E1
Sponsors and Collaborators
Baycrest
  More Information

No publications provided

Responsible Party: Deirdre Dawson, Senior Scientist, Baycrest
ClinicalTrials.gov Identifier: NCT01163279     History of Changes
Other Study ID Numbers: REB1021
Study First Received: July 14, 2010
Last Updated: March 21, 2012
Health Authority: Canada: Ethics Review Committee

Keywords provided by Baycrest:
Age-related changes

ClinicalTrials.gov processed this record on April 14, 2014